4-hydroxy-2H-pyrido[1,2-a]pyrimidin-2-one, 98%, 5g

2'-(Methylthio)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one, 97%, 50mg

Acido caffeico, minimo 98%, 5 g, confezione in vetro

2,3-Difluoro-N,N-dimethylbenzamide, 95%, 500mg

(S)-2-Aminonon-8-enoic acid, 95.0%, 250mg

6-Methoxy-2-methylquinoline>98.0%(GC)(T)5g

1-tert-Butyl 3-methyl 3-hydroxypyrrolidine-1,3-dicarboxylate, 95.0%, 250mg

(S)-2-(5-(Dimethylamino)naphthalene-1-sulfonamido)-3-methylbutanoic acid, 5g

Methyl 3-Amino-5-trifluoromethylbenzoate, 95.0%, 1g

(2-Bromoethyl)diphenylsulfonium trifluoromethanesulfonate, 97%, 25g

Methyl 3-amino-5-nitrothiophene-2-carboxylate, 95+%, 2.5g

Ansa per inoculazione, occhi Ø 2,5 mm, 70 mm 10 pz

Acetato di etile, minimo 99,5%, per sintesi, 25 l, banda stagnata.